Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 363

1.

Implementing a minimally invasive approach (combining radial approach, small guiding catheters and minimization of double access) for coronary chronic total occlusion intervention according to the hybrid algorithm: The Minimalistic Hybrid Algorithm.

Zivelonghi C, van Kuijk JP, Suttorp MJ, van der Heyden JAS, Eefting FD, Rensing BJ, Ten Berg JM, Agostoni P.

Int J Cardiol. 2018 Nov 9. pii: S0167-5273(18)32016-3. doi: 10.1016/j.ijcard.2018.11.021. [Epub ahead of print]

PMID:
30449693
2.

Long-term results of carotid stenting and risk factors in patients with severe carotid artery stenosis undergoing subsequent cardiac surgery.

Habib N, Mahmoodi BK, Suttorp MJ, Kelder JC, Tromp SC, Sonker U, Van der Heyden J.

Catheter Cardiovasc Interv. 2018 Nov 9. doi: 10.1002/ccd.27947. [Epub ahead of print]

PMID:
30411845
3.

Three-year Follow-up of the Randomized Comparison between Everolimus-eluting Bioresorbable Scaffold and Durable Polymer Everolimus-eluting Metallic Stent in Patients with ST-segment Elevation Myocardial Infarction (TROFI II Trial).

Katagiri Y, Onuma Y, Asano T, Iñiguez A, Jensen LO, Cequier À, Hofma SH, Christiansen EH, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys PW.

EuroIntervention. 2018 Nov 6. pii: EIJ-D-18-00839. doi: 10.4244/EIJ-D-18-00839. [Epub ahead of print] No abstract available.

4.

A mathematical model of white blood cell dynamics during maintenance therapy of childhood acute lymphoblastic leukemia.

Le TTT, Jost F, Raupach T, Zierk J, Rauh M, Suttorp M, Stanulla M, Metzler M, Sager S.

Math Med Biol. 2018 Oct 24. doi: 10.1093/imammb/dqy017. [Epub ahead of print]

PMID:
30357334
5.

Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma.

Horváth-Puhó E, Suttorp MM, Frederiksen H, Hoekstra T, Dekkers OM, Pedersen L, Cannegieter SC, Dekker FW, Sørensen HT.

Clin Epidemiol. 2018 Sep 28;10:1371-1380. doi: 10.2147/CLEP.S172306. eCollection 2018.

6.

Angiographic and clinical outcomes of antegrade versus retrograde techniques for chronic total occlusion revascularizations: Insights from the PRISON IV trial.

Zivelonghi C, van Andel M, Venturi G, Amoroso G, Teeuwen K, Tijssen JGP, Tavella D, Ribichini F, Ten Berg JM, Resning BJ, Henriques JPS, Suttorp MJ, Agostoni P, Van der Schaaf RJ.

Catheter Cardiovasc Interv. 2018 Oct 2. doi: 10.1002/ccd.27795. [Epub ahead of print]

PMID:
30280464
7.

The effect of revascularization of a chronic total coronary occlusion on electrocardiographic variables. A sub-study of the EXPLORE trial.

van Dongen IM, Kolk MZH, Elias J, Meijborg VMF, Coronel R, de Bakker JMT, Claessen BEPM, Delewi R, Ouweneel DM, Scheunhage EM, van der Schaaf RJ, Suttorp MJ, Bax M, Marques KM, Postema PG, Wilde AAM, Henriques JPS.

J Electrocardiol. 2018 Sep - Oct;51(5):906-912. doi: 10.1016/j.jelectrocard.2018.07.012. Epub 2018 Jul 19.

8.

Temporal trends in the proportion of "cure" in children, adolescents, and young adults diagnosed with chronic myeloid leukemia in England: A population-based study.

Drozdov D, Bonaventure A, Nakata K, Suttorp M, Belot A.

Pediatr Blood Cancer. 2018 Dec;65(12):e27422. doi: 10.1002/pbc.27422. Epub 2018 Aug 31.

PMID:
30168243
9.

Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients.

Suttorp M, Metzler M, Millot F, Shimada H, Bansal D, Günes AM, Kalwak K, Sedlacek P, Baruchel A, Biondi A, Hijiya N, Schultz KR, Schrappe M.

Pediatr Blood Cancer. 2018 Dec;65(12):e27431. doi: 10.1002/pbc.27431. Epub 2018 Aug 30.

PMID:
30160364
10.

Impact of collateralisation to a concomitant chronic total occlusion in patients with ST-elevation myocardial infarction: a subanalysis of the EXPLORE randomised controlled trial.

van Dongen IM, Elias J, van Houwelingen KG, Agostoni P, Claessen BEPM, Hoebers LP, Ouweneel DM, Scheunhage EM, Delewi R, Piek JJ, Råmunddal T, Laanmets P, Eriksen E, Bax M, Suttorp MJ, van der Schaaf RJ, Tijssen JGP, Henriques JPS.

Open Heart. 2018 Jul 16;5(2):e000810. doi: 10.1136/openhrt-2018-000810. eCollection 2018.

11.

Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trial.

Kuhlen M, Bader P, Sauer M, Albert MH, Gruhn B, Güngör T, Kropshofer G, Lang P, Lawitschka A, Metzler M, Pentek F, Rossig C, Schlegel PG, Schrappe M, Schrum J, Schulz A, Schwinger W, von Stackelberg A, Strahm B, Suttorp M, Luettichau IT, Wößmann W, Borkhardt A, Meisel R, Poetschger U, Glogova E, Peters C.

Br J Haematol. 2018 Oct;183(1):104-109. doi: 10.1111/bjh.15511. Epub 2018 Jul 20.

PMID:
30028016
12.

Identification and Quantification of Heterogeneously-methylated DNA Fragments Using Epiallele-sensitive Droplet Digital Polymerase Chain Reaction (EAST-ddPCR).

Menschikowski M, Jandeck C, Friedemann M, Richter S, Thiem D, Lange BS, Suttorp M.

Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):299-312. doi: 10.21873/cgp.20088.

13.

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial.

Suttorp M, Schulze P, Glauche I, Göhring G, von Neuhoff N, Metzler M, Sedlacek P, de Bont ESJM, Balduzzi A, Lausen B, Aleinikova O, Sufliarska S, Henze G, Strauss G, Eggert A, Kremens B, Groll AH, Berthold F, Klein C, Groß-Wieltsch U, Sykora KW, Borkhardt A, Kulozik AE, Schrappe M, Nowasz C, Krumbholz M, Tauer JT, Claviez A, Harbott J, Kreipe HH, Schlegelberger B, Thiede C.

Leukemia. 2018 Jul;32(7):1657-1669. doi: 10.1038/s41375-018-0179-9. Epub 2018 Jun 20.

PMID:
29925908
14.

Impact of ultra-thin struts on restenosis after chronic total occlusion recanalization: Insights from the randomized PRISON IV trial.

Zivelonghi C, Teeuwen K, Agostoni P, van der Schaaf RJ, Ribichini F, Adriaenssens T, Kelder JC, Tijssen JGP, Henriques JPS, Suttorp MJ.

J Interv Cardiol. 2018 Oct;31(5):580-587. doi: 10.1111/joic.12516. Epub 2018 May 1.

PMID:
29717512
15.

Molecular profile of inflammatory and megakaryocytic factors in pediatric myelodysplastic syndrome with acute myelofibrosis.

Hussein K, Suttorp M, Stucki-Koch A, Baumann I, Niemeyer CM, Kreipe H.

Pediatr Blood Cancer. 2018 Jul;65(7):e27048. doi: 10.1002/pbc.27048. Epub 2018 Apr 18.

PMID:
29667765
16.

Duodenocolonic Fistula As A Rare Complication of Intestinal Burkitt Lymphoma in a Three-Year-Old Boy.

Okuda KV, Laass M, Schuchardt K, Lange BS, Knöfler R, Fitze G, Woessmann W, Suttorp M.

Klin Padiatr. 2018 Apr;230(3):138-141. doi: 10.1055/a-0586-4045. Epub 2018 Apr 4.

PMID:
29618138
17.

Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.

Elias J, van Dongen IM, Råmunddal T, Laanmets P, Eriksen E, Meuwissen M, Michels HR, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Marques KM, Claessen BEPM, Hirsch A, van der Schaaf RJ, Tijssen JGP, Henriques JPS, Hoebers LP; EXPLORE investigators.

Heart. 2018 Sep;104(17):1432-1438. doi: 10.1136/heartjnl-2017-312698. Epub 2018 Feb 20.

PMID:
29463612
18.

First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm.

Zivelonghi C, van Kuijk JP, Nijenhuis V, Poletti E, Suttorp MJ, van der Heyden JAS, Eefting FD, Rensing BJ, Ten Berg JM, Azzalini L, van den Brink FS, Ribichini F, Colombo A, Henriques JPS, Agostoni P.

Catheter Cardiovasc Interv. 2018 Nov 1;92(5):E299-E307. doi: 10.1002/ccd.27539. Epub 2018 Feb 7.

PMID:
29411523
19.

Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood.

Toepfner N, Herold C, Otto O, Rosendahl P, Jacobi A, Kräter M, Stächele J, Menschner L, Herbig M, Ciuffreda L, Ranford-Cartwright L, Grzybek M, Coskun Ü, Reithuber E, Garriss G, Mellroth P, Henriques-Normark B, Tregay N, Suttorp M, Bornhäuser M, Chilvers ER, Berner R, Guck J.

Elife. 2018 Jan 13;7. pii: e29213. doi: 10.7554/eLife.29213.

20.

Veno-arterial extracorporeal membrane oxygenation in addition to primary PCI in patients presenting with ST-elevation myocardial infarction.

van den Brink FS, Magan AD, Noordzij PG, Zivelonghi C, Agostoni P, Eefting FD, Ten Berg JM, Suttorp MJ, Rensing BR, van Kuijk JP, Klein P, Scholten E, van der Heyden JAS.

Neth Heart J. 2018 Feb;26(2):76-84. doi: 10.1007/s12471-017-1068-y.

21.

Serum Interleukin-6 and CCL11/Eotaxin May Be Suitable Biomarkers for the Diagnosis of Chronic Nonbacterial Osteomyelitis.

Hofmann SR, Böttger F, Range U, Lück C, Morbach H, Girschick HJ, Suttorp M, Hedrich CM.

Front Pediatr. 2017 Dec 1;5:256. doi: 10.3389/fped.2017.00256. eCollection 2017.

22.

Percutaneous closure of a patent foramen ovale after cryptogenic stroke.

Snijder RJR, Suttorp MJ, Ten Berg JM, Post MC.

Neth Heart J. 2018 Jan;26(1):5-12. doi: 10.1007/s12471-017-1063-3. Review.

23.

Off‑target effect of imatinib and nilotinib on human vitamin D3 metabolism.

Kroschwald L, Suttorp M, Tauer JT, Zimmermann N, Günther C, Bauer A.

Mol Med Rep. 2018 Jan;17(1):1382-1388. doi: 10.3892/mmr.2017.7952. Epub 2017 Nov 3.

PMID:
29115640
24.

Pharmacology and pharmacokinetics of imatinib in pediatric patients.

Suttorp M, Bornhäuser M, Metzler M, Millot F, Schleyer E.

Expert Rev Clin Pharmacol. 2018 Mar;11(3):219-231. doi: 10.1080/17512433.2018.1398644. Epub 2017 Nov 6. Review.

PMID:
29076384
25.

Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.

Yamaji K, Brugaletta S, Sabaté M, Iñiguez A, Jensen LO, Cequier A, Hofma SH, Christiansen EH, Suttorp M, van Es GA, Sotomi Y, Onuma Y, Serruys PW, Windecker S, Räber L.

JACC Cardiovasc Interv. 2017 Sep 25;10(18):1867-1877. doi: 10.1016/j.jcin.2017.07.035.

26.

Feasibility of multiplane microtransoesophageal echocardiographic guidance in structural heart disease transcatheter interventions in adults.

Nijenhuis VJ, Alipour A, Wunderlich NC, Rensing BJWM, Gijsbers G, Ten Berg JM, Suttorp MJ, Boersma LVA, van der Heyden JAS, Swaans MJ.

Neth Heart J. 2017 Dec;25(12):669-674. doi: 10.1007/s12471-017-1036-6.

27.

Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents.

Millot F, Guilhot J, Suttorp M, Güneş AM, Sedlacek P, De Bont E, Li CK, Kalwak K, Lausen B, Culic S, Dworzak M, Kaiserova E, De Moerloose B, Roula F, Biondi A, Baruchel A.

Haematologica. 2017 Oct;102(10):1704-1708. doi: 10.3324/haematol.2017.170035. Epub 2017 Aug 24.

28.

The complexity of growth failure in children receiving tyrosine kinase inhibitor therapy for chronic myelogenous leukemia.

Samis J, Lee P, Zimmerman D, Suttorp M, Hijiya N.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26703. Epub 2017 Jul 11. No abstract available.

PMID:
28696050
29.

Treatment of high-grade osteoblastic osteosarcoma of the humerus in a 5-year-old boy with cystic fibrosis: A case report.

Okuda KV, Hammermann J, Lange BS, Fischer JC, Thielemann F, Knöfler R, Suttorp M.

Mol Clin Oncol. 2017 Jul;7(1):148-150. doi: 10.3892/mco.2017.1274. Epub 2017 May 29.

30.

A case of rivaroxaban-associated acute tubulointerstitial nephritis.

Monahan RC, Suttorp MM, Gabreëls BATF.

Neth J Med. 2017 May;75(4):169-171.

31.

Optical coherence tomography findings: insights from the "randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions" (PRISON IV) trial.

Teeuwen K, Spoormans EM, Bennett J, Dubois C, Desmet W, Ughi GJ, Belmans A, Kelder JC, Tijssen JGP, Agostoni P, Suttorp MJ, Adriaenssens T.

EuroIntervention. 2017 Aug 4;13(5):e522-e530. doi: 10.4244/EIJ-D-17-00261.

32.

Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents.

Millot F, Dupraz C, Guilhot J, Suttorp M, Brizard F, Leblanc T, Güneş AM, Sedlacek P, De Bont E, Li CK, Kalwak K, Lausen B, Culic S, Dworzak M, Kaiserova E, De Moerloose B, Roula F, Biondi A, Baruchel A, Guilhot F.

Cancer. 2017 Sep 15;123(18):3609-3616. doi: 10.1002/cncr.30767. Epub 2017 May 12.

33.

Acute Cerebral Symptoms in a Child with Down Syndrome and Acute Leukemia - What has to be Considered?

Benecke N, Lange BS, Suttorp M, Hahn G, Knöfler R.

Klin Padiatr. 2017 May;229(3):177-179. doi: 10.1055/s-0042-124665. Epub 2017 Apr 4. No abstract available.

PMID:
28376541
34.

Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis.

Hussein K, Stucki-Koch A, Göhring G, Kreipe H, Suttorp M.

Leukemia. 2017 Jul;31(7):1540-1546. doi: 10.1038/leu.2017.73. Epub 2017 Feb 27.

PMID:
28239144
35.

Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial.

Teeuwen K, van der Schaaf RJ, Adriaenssens T, Koolen JJ, Smits PC, Henriques JP, Vermeersch PH, Tjon Joe Gin RM, Schölzel BE, Kelder JC, Tijssen JG, Agostoni P, Suttorp MJ.

JACC Cardiovasc Interv. 2017 Jan 23;10(2):133-143. doi: 10.1016/j.jcin.2016.10.017.

36.

Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy.

Proschmann R, Baldow C, Rothe T, Suttorp M, Thiede C, Tauer JT, Müller MC, Hochhaus A, Roeder I, Glauche I.

Haematologica. 2017 Feb;102(2):e39-e42. doi: 10.3324/haematol.2016.154138. Epub 2016 Nov 17. No abstract available.

37.

Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial.

Henriques JP, Hoebers LP, Råmunddal T, Laanmets P, Eriksen E, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Nijveldt R, van Rossum AC, Marques KM, Elias J, van Dongen IM, Claessen BE, Tijssen JG, van der Schaaf RJ; EXPLORE Trial Investigators.

J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632. doi: 10.1016/j.jacc.2016.07.744.

38.

Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia.

Samis J, Lee P, Zimmerman D, Arceci RJ, Suttorp M, Hijiya N.

Pediatr Blood Cancer. 2016 Aug;63(8):1332-8. doi: 10.1002/pbc.26028. Epub 2016 Apr 21. Review.

PMID:
27100618
39.

Novel Mutation in the DKC1 Gene: Neonatal Hoyeraal-Hreidarsson Syndrome As a Rare Differential Diagnosis in Pontocerebellar Hypoplasia, Primary Microcephaly, and Progressive Bone Marrow Failure.

Dehmel M, Brenner S, Suttorp M, Hahn G, Schützle H, Dinger J, Di Donato N, Mackenroth L, von der Hagen M.

Neuropediatrics. 2016 Jun;47(3):182-6. doi: 10.1055/s-0036-1578799. Epub 2016 Mar 7.

PMID:
26951492
40.

Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The 'wait a day' approach might be safer.

Oosterwerff EF, Fagel ND, Slagboom T, Tijssen JG, Herrman JP, Smits PC, Suttorp MJ, Ronner E, Laarman GJ, Patterson MS, Amoroso G, Vink MA, van der Schaaf RJ, Verheugt FW, Riezebos RK.

Neth Heart J. 2016 Mar;24(3):173-80. doi: 10.1007/s12471-016-0803-0.

41.

Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group.

Cseh AM, Niemeyer CM, Yoshimi A, Catala A, Frühwald MC, Hasle H, van den Heuvel-Eibrink MM, Lauten M, De Moerloose B, Smith OP, Bernig T, Gruhn B, Kulozik AE, Metzler M, Olcay L, Suttorp M, Furlan I, Strahm B, Flotho C.

Br J Haematol. 2016 Mar;172(6):930-6. doi: 10.1111/bjh.13915. Epub 2016 Jan 13.

PMID:
26766110
42.

Mechanical Stress Changes the Complex Interplay Between HO-1, Inflammation and Fibrosis, During Excisional Wound Repair.

Cremers NA, Suttorp M, Gerritsen MM, Wong RJ, van Run-van Breda C, van Dam GM, Brouwer KM, Kuijpers-Jagtman AM, Carels CE, Lundvig DM, Wagener FA.

Front Med (Lausanne). 2015 Dec 15;2:86. doi: 10.3389/fmed.2015.00086. eCollection 2015.

43.

Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention in Multivessel Coronary Disease Is Primarily Related to Stent Failure: Post-Hoc Analysis of the PASSION Trial.

Vink MA, Vos NS, Dirksen MT, Suttorp MJ, Slagboom T, Patterson MS, Kiemeneij F, Laarman G.

J Interv Cardiol. 2015 Dec;28(6):523-30. doi: 10.1111/joic.12246.

PMID:
26643000
44.

Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition Syndromes.

Weber ML, Schneider DT, Offenmüller S, Kaatsch P, Einsiedel HG, Benesch M, Claviez A, Ebinger M, Kramm C, Kratz C, Lawlor J, Leuschner I, Merkel S, Metzler M, Nustede R, Petsch S, Seeger KH, Schlegel PG, Suttorp M, Zolk O, Brecht IB.

Pediatr Blood Cancer. 2016 Apr;63(4):611-7. doi: 10.1002/pbc.25839. Epub 2015 Nov 17.

PMID:
26575411
45.

Pediatric chronic myeloid leukemia is a unique disease that requires a different approach.

Hijiya N, Schultz KR, Metzler M, Millot F, Suttorp M.

Blood. 2016 Jan 28;127(4):392-9. doi: 10.1182/blood-2015-06-648667. Epub 2015 Oct 28.

46.

Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.

Sabaté M, Windecker S, Iñiguez A, Okkels-Jensen L, Cequier A, Brugaletta S, Hofma SH, Räber L, Christiansen EH, Suttorp M, Pilgrim T, Anne van Es G, Sotomi Y, García-García HM, Onuma Y, Serruys PW.

Eur Heart J. 2016 Jan 14;37(3):229-40. doi: 10.1093/eurheartj/ehv500. Epub 2015 Sep 23.

47.

Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials.

Wijns W, Suttorp MJ, Zagozdzon L, Morice MC, McClean D, Stella P, Donohoe D, Knape C, Ormiston J.

EuroIntervention. 2016 Jun 20;12(3):352-5. doi: 10.4244/EIJY15M09_14.

48.

Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study.

Räber L, Onuma Y, Brugaletta S, Garcia-Garcia HM, Backx B, Iñiguez A, Okkels Jensen L, Cequier-Fillat À, Pilgrim T, Christiansen EH, Hofma SH, Suttorp M, Serruys PW, Sabaté M, Windecker S.

EuroIntervention. 2016 Jul 20;12(4):482-9. doi: 10.4244/EIJY15M08_03.

49.

Treatment with high dose of erythropoiesis-stimulating agents and mortality: analysis with a sequential Cox approach and a marginal structural model.

Suttorp MM, Hoekstra T, Mittelman M, Ott I, Krediet RT, Dekker FW, Putter H.

Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1068-75. doi: 10.1002/pds.3855. Epub 2015 Aug 12.

PMID:
26265483
50.

Trends in haemoglobin, erythropoietin-stimulating agents and iron use in Swedish chronic kidney disease patients between 2008 and 2013.

Evans M, Suttorp MM, Bellocco R, Hoekstra T, Qureshi AR, Dekker FW, Carrero JJ.

Nephrol Dial Transplant. 2016 Apr;31(4):628-35. doi: 10.1093/ndt/gfv298. Epub 2015 Aug 4.

PMID:
26243782

Supplemental Content

Loading ...
Support Center